SCHEMBL29312920

SCHEMBL29312920

CCCCC/C=C\C/C=C\CCCCCCCCN(CCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCNC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.50
CNR2 P34972 2/20 0.50
ALDH1A1 P00352 6/20 0.49
HPGD P15428 2/20 0.49
MAPT P10636 2/20 0.49
FAAH O00519 1/20 0.49
KDM4E B2RXH2 4/20 0.47
MGLL Q99685 1/20 0.47
F7 P08709 3/20 0.47
F3 P13726 3/20 0.47
PPARG P37231 2/20 0.47
PPARD Q03181 2/20 0.47
PPARA Q07869 2/20 0.47
DUSP3 P51452 1/20 0.47
PTPN7 P35236 1/20 0.47
FFAR1 O14842 1/20 0.47
LMNA P02545 1/20 0.47
FABP3 P05413 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP19A1 P11511 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20139394 0.85 CNR1 (0.51) CNR1CNR2ALDH1A1HPGDMAPT
SCHEMBL20018254 0.85 CNR1 (0.51) CNR1CNR2ALDH1A1HPGDMAPT
SCHEMBL24728770 0.84 ALDH1A1 (0.51) ALDH1A1HPGDKDM4EMGLLF7
SCHEMBL27903374 0.83 CNR1 (0.62) CNR1CNR2ALDH1A1HPGDKDM4E
SCHEMBL24728824 0.82 FABP3 (0.47) ALDH1A1HPGDKDM4EF7F3
SCHEMBL6448523 0.82 TERT (0.54) CNR2MAPTFAAHF7F3
SCHEMBL24728662 0.81 CNR1 (0.54) CNR1CNR2ALDH1A1HPGDKDM4E
SCHEMBL27639762 0.81 CNR1 (0.68) CNR1CNR2ALDH1A1HPGDMAPT
SCHEMBL24728762 0.80 CNR1 (0.55) CNR1CNR2ALDH1A1HPGDMAPT
SCHEMBL20146345 0.79 CNR1 (0.50) CNR1ALDH1A1HPGDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226132-A1 RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2024-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240226132-A1 RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME SNRPB2, NSUN2, RNMT CNR1 3657/4885CNR2 4356/4885ALDH1A1 3185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.